MAM
Timex ‘Life is Ticking’ campaign kicks off next month
CONNECTICUT: Watch manufacturer Timex Corporation has announced the launch of a global advertising campaign with a newly developed tagline, “Life is Ticking”.
The campaign was created by Kirshenbaum Bond & Partners, New York.
It includes print, online and cinema advertising executions and will appear from next month. Explaining the strategy, Timex’s senior marketing vice president Mark Shuster was quoted in an official release, as saying, “Over time, Timex has built one of the most innovative and well-designed product lines in the industry. And now we are redirecting all of our marketing efforts to let the world know it. With this new campaign, we are firing the first salvo in the battle to capture attention and — more importantly — change perceptions.”
“Life is Ticking” is a modern evolution of the tag “It takes a licking and keeps on ticking”. The release adds that the new tagline gives a respectful nod to the old while sending the message that Timex is a contemporary and relevant brand.
The bold, simplistic and graphic “Life is Ticking” print campaign leverages wry visual humour and subtle product hints paired with minimal copy. The release says, the ad allows consumers to make the connection between Timex’s innovative product attributes and their implication in everyday life. Each visual execution depicts a slightly exaggerated real world “problem”, in which Timex product offers the solution.
For example, one ad shows two pairs of legs peeking out from under tangled blankets in a dark bedroom. A Timex watch sits underneath the photo. The copy reads “Indiglo Night Light”, — highlighting Timex’s watch illumination technology.
The campaign aims at demonstrating how Timex helps one to make the most out of time, and the most out of life. For instance, instead of showing a guy with a Timex digital compass in the woods, the ads show how a Timex can help in finding your way through the sameness of suburbia, states the release.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
